Bruce C. Cozadd

2012

In 2012, Bruce C. Cozadd earned a total compensation of $11.1M as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 209% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,081,600
Option Awards$4,627,340
Salary$722,158
Stock Awards$4,682,990
Other$1,710
Total$11,115,798

Cozadd received $4.7M in stock awards, accounting for 42% of the total pay in 2012.

Cozadd also received $1.1M in non-equity incentive plan, $4.6M in option awards, $722.2K in salary and $1.7K in other compensation.

Rankings

In 2012, Bruce C. Cozadd's compensation ranked 347th out of 11,487 executives tracked by ExecPay. In other words, Cozadd earned more than 97.0% of executives.

ClassificationRankingPercentile
All
347
out of 11,487
97th
Division
Manufacturing
130
out of 4,253
97th
Major group
Chemicals And Allied Products
27
out of 1,203
98th
Industry group
Drugs
14
out of 925
99th
Industry
Pharmaceutical Preparations
11
out of 700
98th
Source: SEC filing on June 10, 2015.

Cozadd's colleagues

We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2012.

2012

Suzanne Hooper

Jazz Pharmaceuticals

General Counsel

2012

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

2012

Jeffrey Tobias

Jazz Pharmaceuticals

Chief Medical Officer

2012

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

News

You may also like